Range of CR at 450 day markNot clear if they will use the data as-is from the ASCO poster to submit a request for BTD, in which case 450 day CR stands at 28% (8 of 29) as stated. There were 3 IRs waiting to be re-categorized at the 450 day mark…and 4 more left to move from 360 day to 450 day mark (2 were CRs, 2 were IRs). Total of 7 additional data points. ASSUMING they were waiting for those 4 patients (from 360 day) to move into the 450 day slot AND assuming they ALL happened in Q1, then, best case would be all 4+3 are CR (15 total CRs at 450 day mark meaning ~ 40% CR@450). Worst case would be none of the 7 were CR which means 8 total CRs remains as-is at 450 day mark….which is ~22% CR@450). The real results are likely to be somewhere in between ie 22% to 40%. Still better than Keytruda. I didn’t exactly score high in math, so could be way off. It all depends on when they filed, or plan to file. It also depends on how the FDA reads the data and evaluations. GLTA.